UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (Date of earliest event reported): May 20, 2019
Ensco Rowan plc
(Exact name of registrant as specified in its charter)
England and Wales
 
1-8097
 
98-0635229
(State or other jurisdiction of
incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
6 Chesterfield Gardens
London, England W1J 5BQ
(Address of Principal Executive Offices and Zip Code)
Registrant’s telephone number, including area code: 44 (0) 20 7659 4660
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined by Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company ¨       
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨  

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Class A Ordinary Shares, U.S. $0.40 par value
ESV
New York Stock Exchange







TABLE OF CONTENTS






Item 5.07 Submission of Matters to a Vote of Security Holders
(a) The Company held its 2019 Annual General Meeting in London, England on May 20, 2019.
(b) There were 437,388,656 shares entitled to vote at the meeting based on the March 25, 2019 record date, of which 361,703,758 shares, or approximately 82.69%, were present and voting in person or by proxy. The following matters, detailed descriptions of which are contained in the 2019 Proxy Statement, were voted on at the meeting:
(1) To re-elect Directors to serve until the 2020 Annual General Meeting of Shareholders:
a. J. Roderick Clark
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
292,115,605
 
2,354,616
 
856,855
 
66,376,682

b. Mary E. Francis CBE
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
292,610,113
 
2,096,380
 
620,583
 
66,376,682

c. C. Christopher Gaut
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
221,348,350
 
73,083,936
 
894,790
 
66,376,682

d. Keith O. Rattie
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
292,044,563
 
2,387,651
 
894,862
 
66,376,682

e. Paul E. Rowsey, III
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
289,281,723
 
5,141,352
 
904,001
 
66,376,682

f. Carl G. Trowell
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
291,750,700
 
2,928,221
 
648,155
 
66,376,682

(2) Because the Rowan Transaction (as defined in the proxy statement) was completed prior to the 2019
Annual General Meeting, Resolutions 2a. - e. were withdrawn and were not considered at the
Meeting.

2



(3) To elect Directors to serve until the 2020 Annual General Meeting of Shareholders.
a. Dr. Thomas Burke
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
292,726,628
 
1,874,197
 
726,251
 
66,376,682

b. William E. Albrecht
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
292,657,876
 
1,943,651
 
725,549
 
66,376,682

c. Suzanne P. Nimocks
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
292,930,046
 
1,717,710
 
679,320
 
66,376,682

d. Thierry Pilenko
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
291,144,366
 
3,477,931
 
704,779
 
66,376,682

e. Charles L. Szews
 
 
 
 
 
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
292,962,487
 
1,656,123
 
708,466
 
66,376,682

(4) To ratify the Audit Committee's appointment of KPMG LLP (U.S.) as our U.S. independent registered public accounting firm for the fiscal year ending 31 December 2019:
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
354,030,603
 
6,522,690
 
1,150,465
 
N/A

(5) To appoint KPMG LLP (U.K.) as our U.K. statutory auditors under the U.K. Companies Act 2006 (to hold office from the conclusion of the 2019 Annual General Meeting of Shareholders until the conclusion of the next Annual General Meeting of Shareholders at which accounts are laid before the Company):
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
354,446,031
 
6,084,456
 
1,173,271
 
N/A


3



(6) To authorise the Audit Committee to determine our U.K. statutory auditors' remuneration:
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
353,777,934
 
6,774,441
 
1,151,383
 
N/A

(7) A non-binding advisory vote to approve the Directors' Remuneration Report for the year ended 31 December 2018:
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
288,306,461
 
5,146,156
 
1,874,459
 
66,376,682

(8) A non-binding advisory vote to approve the compensation of our named executive officers:
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
286,237,989
 
7,254,982
 
1,834,105
 
66,376,682

(9) A non-binding advisory vote to approve the reports of the auditors and the directors and the U.K. statutory accounts for the year ended 31 December 2018:
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
355,148,187
 
3,543,152
 
3,012,419
 
N/A

(10) To authorise the Board of Director to allot shares, the full text of which can be found in "Resolution 10" of the proxy statement:
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
283,355,840
 
74,953,925
 
3,393,993
 
N/A

(11) To approve the general disapplication of pre-emption rights, the full text of which can be found in “Resolution 11” of the proxy statement:
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
319,661,270
 
38,810,324
 
3,232,164
 
N/A

(12) To approve the disapplication of pre-emption rights in connection with an acquisition or specified capital investment, the full text of which can be found in “Resolution 12” of the proxy statement:
 
 
 
 
 
 
Broker
Votes For
 
Votes Against
 
Votes Abstain
 
Non-Votes
330,194,756
 
27,927,358
 
3,581,644
 
N/A

4




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
Ensco Rowan plc
 
 
 
Date: May 20, 2019
 
 /s/ Michael T. McGuinty      
Michael T. McGuinty
Senior Vice President - General Counsel and Secretary

5
Ensco (NYSE:ESV)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ensco Charts.
Ensco (NYSE:ESV)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ensco Charts.